149 related articles for article (PubMed ID: 34699642)
1. Sialoglycans on lymphatic endothelial cells augment interactions with Siglec-1 (CD169) of lymph node macrophages.
D'Addio M; Frey J; Tacconi C; Commerford CD; Halin C; Detmar M; Cummings RD; Otto VI
FASEB J; 2021 Nov; 35(11):e22017. PubMed ID: 34699642
[TBL] [Abstract][Full Text] [Related]
2. Prognostic significance of CD169-positive lymph node sinus macrophages in patients with endometrial carcinoma.
Ohnishi K; Yamaguchi M; Erdenebaatar C; Saito F; Tashiro H; Katabuchi H; Takeya M; Komohara Y
Cancer Sci; 2016 Jun; 107(6):846-52. PubMed ID: 26991548
[TBL] [Abstract][Full Text] [Related]
3. CD169 mediates the capture of exosomes in spleen and lymph node.
Saunderson SC; Dunn AC; Crocker PR; McLellan AD
Blood; 2014 Jan; 123(2):208-16. PubMed ID: 24255917
[TBL] [Abstract][Full Text] [Related]
4. Identification of sialoadhesin as a dominant lymph node counter-receptor for mouse macrophage galactose-type C-type lectin 1.
Kumamoto Y; Higashi N; Denda-Nagai K; Tsuiji M; Sato K; Crocker PR; Irimura T
J Biol Chem; 2004 Nov; 279(47):49274-80. PubMed ID: 15364954
[TBL] [Abstract][Full Text] [Related]
5. Melanoma exosome induction of endothelial cell GM-CSF in pre-metastatic lymph nodes may result in different M1 and M2 macrophage mediated angiogenic processes.
Hood JL
Med Hypotheses; 2016 Sep; 94():118-22. PubMed ID: 27515216
[TBL] [Abstract][Full Text] [Related]
6. Comparative Transcriptomic Analysis Identifies a Range of Immunologically Related Functional Elaborations of Lymph Node Associated Lymphatic and Blood Endothelial Cells.
Berendam SJ; Koeppel AF; Godfrey NR; Rouhani SJ; Woods AN; Rodriguez AB; Peske JD; Cummings KL; Turner SD; Engelhard VH
Front Immunol; 2019; 10():816. PubMed ID: 31057546
[TBL] [Abstract][Full Text] [Related]
7. Mouse Siglec-1 Mediates trans-Infection of Surface-bound Murine Leukemia Virus in a Sialic Acid N-Acyl Side Chain-dependent Manner.
Erikson E; Wratil PR; Frank M; Ambiel I; Pahnke K; Pino M; Azadi P; Izquierdo-Useros N; Martinez-Picado J; Meier C; Schnaar RL; Crocker PR; Reutter W; Keppler OT
J Biol Chem; 2015 Nov; 290(45):27345-27359. PubMed ID: 26370074
[TBL] [Abstract][Full Text] [Related]
8. Targeted delivery of lipid antigen to macrophages via the CD169/sialoadhesin endocytic pathway induces robust invariant natural killer T cell activation.
Kawasaki N; Vela JL; Nycholat CM; Rademacher C; Khurana A; van Rooijen N; Crocker PR; Kronenberg M; Paulson JC
Proc Natl Acad Sci U S A; 2013 May; 110(19):7826-31. PubMed ID: 23610394
[TBL] [Abstract][Full Text] [Related]
9. The Clinical Significance of CD169-Positive Lymph Node Macrophage in Patients with Breast Cancer.
Shiota T; Miyasato Y; Ohnishi K; Yamamoto-Ibusuki M; Yamamoto Y; Iwase H; Takeya M; Komohara Y
PLoS One; 2016; 11(11):e0166680. PubMed ID: 27861544
[TBL] [Abstract][Full Text] [Related]
10. Sialoadhesin (CD169/Siglec-1) is an extended molecule that escapes inhibitory cis-interactions and synergizes with other macrophage receptors to promote phagocytosis.
Klaas M; Dubock S; Ferguson DJP; Crocker PR
Glycoconj J; 2023 Apr; 40(2):213-223. PubMed ID: 36738392
[TBL] [Abstract][Full Text] [Related]
11. A Protective Role for the Lectin CD169/Siglec-1 against a Pathogenic Murine Retrovirus.
Uchil PD; Pi R; Haugh KA; Ladinsky MS; Ventura JD; Barrett BS; Santiago ML; Bjorkman PJ; Kassiotis G; Sewald X; Mothes W
Cell Host Microbe; 2019 Jan; 25(1):87-100.e10. PubMed ID: 30595553
[TBL] [Abstract][Full Text] [Related]
12. Possible functions of CD169-positive sinus macrophages in lymph nodes in anti-tumor immune responses.
Komohara Y; Ohnishi K; Takeya M
Cancer Sci; 2017 Mar; 108(3):290-295. PubMed ID: 28002629
[TBL] [Abstract][Full Text] [Related]
13. Mapping the distinctive populations of lymphatic endothelial cells in different zones of human lymph nodes.
Park SM; Angel CE; McIntosh JD; Mansell C; Chen CJ; Cebon J; Dunbar PR
PLoS One; 2014; 9(4):e94781. PubMed ID: 24733110
[TBL] [Abstract][Full Text] [Related]
14. Comparison of Protein and Peptide Targeting for the Development of a CD169-Based Vaccination Strategy Against Melanoma.
van Dinther D; Veninga H; Revet M; Hoogterp L; Olesek K; Grabowska J; Borg EGF; Kalay H; van Kooyk Y; den Haan JMM
Front Immunol; 2018; 9():1997. PubMed ID: 30237798
[TBL] [Abstract][Full Text] [Related]
15. Effect of cytokines on Siglec-1 and HIV-1 entry in monocyte-derived macrophages: the importance of HIV-1 envelope V1V2 region.
Jobe O; Trinh HV; Kim J; Alsalmi W; Tovanabutra S; Ehrenberg PK; Peachman KK; Gao G; Thomas R; Kim JH; Michael NL; Alving CR; Rao VB; Rao M
J Leukoc Biol; 2016 Jun; 99(6):1089-106. PubMed ID: 26667473
[TBL] [Abstract][Full Text] [Related]
16. Engagement of sialylated glycans with Siglec receptors on suppressive myeloid cells inhibits anticancer immunity via CCL2.
Wieboldt R; Sandholzer M; Carlini E; Lin CW; Börsch A; Zingg A; Lardinois D; Herzig P; Don L; Zippelius A; Läubli H; Mantuano NR
Cell Mol Immunol; 2024 May; 21(5):495-509. PubMed ID: 38448555
[TBL] [Abstract][Full Text] [Related]
17. Prognostic Significance of CD169+ Lymph Node Sinus Macrophages in Patients with Malignant Melanoma.
Saito Y; Ohnishi K; Miyashita A; Nakahara S; Fujiwara Y; Horlad H; Motoshima T; Fukushima S; Jinnin M; Ihn H; Takeya M; Komohara Y
Cancer Immunol Res; 2015 Dec; 3(12):1356-63. PubMed ID: 26297710
[TBL] [Abstract][Full Text] [Related]
18. CD169
Camara A; Lavanant AC; Abe J; Desforges HL; Alexandre YO; Girardi E; Igamberdieva Z; Asano K; Tanaka M; Hehlgans T; Pfeffer K; Pfeffer S; Mueller SN; Stein JV; Mueller CG
Proc Natl Acad Sci U S A; 2022 Jan; 119(3):. PubMed ID: 35031565
[TBL] [Abstract][Full Text] [Related]
19. Sialoadhesin - a macrophage-restricted marker of immunoregulation and inflammation.
O'Neill AS; van den Berg TK; Mullen GE
Immunology; 2013 Mar; 138(3):198-207. PubMed ID: 23181380
[TBL] [Abstract][Full Text] [Related]
20. CD169
Tacconi C; Commerford CD; Dieterich LC; Schwager S; He Y; Ikenberg K; Friebel E; Becher B; Tugues S; Detmar M
Cell Rep; 2021 Apr; 35(2):108993. PubMed ID: 33852863
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
